Delaware Code Title 16 Sec. 2602 – Physicians and health-care facilities to screen children
(a) Every health-care provider who is the primary health-care provider for a child shall order lead poisoning screening of the child, under regulations adopted by the Division of Public Health, at or around 12 and 24 months of age.
Terms Used In Delaware Code Title 16 Sec. 2602
- Child: means a person who has not reached the age of 18 years. See Delaware Code Title 1 Sec. 302
- Division: means the Division of Public Health. See Delaware Code Title 16 Sec. 101
- Guardian: A person legally empowered and charged with the duty of taking care of and managing the property of another person who because of age, intellect, or health, is incapable of managing his (her) own affairs.
- Judgement: The official decision of a court finally determining the respective rights and claims of the parties to a suit.
(b) [Repealed.]
(c) (1) If screening under subsection (a) of this section determines that a child has an elevated blood lead level, the health-care provider shall order testing under regulations adopted by the Division of Public Health.
(2) A health-care provider is encouraged to use the health-care provider’s clinical judgement to determine when testing should be used in lieu of screening under subsection (a) of this section.
(d) All laboratories and health-care providers involved in blood lead level analysis, including screening and testing, shall participate in a universal reporting system as established by the Division of Public Health.
(e) Nothing in this section may be construed to require any child to undergo screening or testing if the child’s parent or guardian objects on the grounds that the screening or testing conflicts with the parent’s or guardian’s religious beliefs.
(f) [Repealed.]
69 Del. Laws, c. 310, § ?1; 70 Del. Laws, c. 186, § ?1; 77 Del. Laws, c. 402, §§ ?1, 3; 83 Del. Laws, c. 75, § 2;